top of page

Recent Posts

Change in MYCN-driven cell state opens therapeutic window in high-risk neuroblastoma

Apr 10, 2024

A switch between cell states within MYCN-amplified neuroblastoma promotes KDM4, inhibition of which shows promising anticancer potential.

Read more: https://www.eurekalert.org/news-releases/1038262

Comments

HRD HSCT Shows Promise Among Pediatric Patients With Hematologic Cancers

Treating a deadly childhood cancer with a sideways approach

Childhood Cancer Survivors Have Higher Risk of Chronic Conditions, Early Death

A new CAR-T-cell therapy tricks cancer cells with a decoy to increase treatment efficiency in B-cell Acute Lymphoblastic Leukaemia

Experimental treatment borrowed from blood cancer shows promise for pediatric brain tumors

Classifying childhood brain cancers by immune response may improve diagnostics and treatments

Is Less More? Rethinking Salvage Therapy in Pediatric Hodgkin Lymphoma

Newborns with heart defects may face a higher risk of developing childhood cancer

New therapeutic approach shows promise for pediatric high-grade gliomas

Space-age lessons could protect childhood cancer survivors’ bone health

Archive

Search By Tags

bottom of page